Re­genxbio looks to part­ner neu­rode­gen­er­a­tive gene ther­a­py work, lays off 15% of staff

Re­genxbio has laid off 15% of its staff as it nar­rows down its pipeline to fo­cus on three gene ther­a­py pro­grams.

The Rockville, MD-based biotech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.